SOURCE: Threshold Pharmaceuticals

Threshold Pharmaceuticals

November 01, 2011 05:00 ET

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 1, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 8th Annual Lazard Healthcare Conference in New York City on Tuesday, November 15, 2011 at 10:00AM EST.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (

Contact Information

  • Contact:
    Joel A. Fernandes
    Threshold Pharmaceuticals, Inc.
    Email Contact